157 related articles for article (PubMed ID: 22312561)
1. Susceptibility of bifidobacteria of animal origin to selected antimicrobial agents.
Mayrhofer S; Mair C; Kneifel W; Domig KJ
Chemother Res Pract; 2011; 2011():989520. PubMed ID: 22312561
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products.
Masco L; Van Hoorde K; De Brandt E; Swings J; Huys G
J Antimicrob Chemother; 2006 Jul; 58(1):85-94. PubMed ID: 16698847
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic susceptibility of members of the Lactobacillus acidophilus group using broth microdilution and molecular identification of their resistance determinants.
Mayrhofer S; van Hoek AH; Mair C; Huys G; Aarts HJ; Kneifel W; Domig KJ
Int J Food Microbiol; 2010 Nov; 144(1):81-7. PubMed ID: 20888656
[TBL] [Abstract][Full Text] [Related]
4. Characterization of antimicrobial resistance in lactobacilli and bifidobacteria used as probiotics or starter cultures based on integration of phenotypic and in silico data.
Rozman V; Mohar Lorbeg P; Accetto T; Bogovič Matijašić B
Int J Food Microbiol; 2020 Feb; 314():108388. PubMed ID: 31707173
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market.
Xiao JZ; Takahashi S; Odamaki T; Yaeshima T; Iwatsuki K
Biosci Biotechnol Biochem; 2010; 74(2):336-42. PubMed ID: 20139616
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use.
Klare I; Konstabel C; Werner G; Huys G; Vankerckhoven V; Kahlmeter G; Hildebrandt B; Müller-Bertling S; Witte W; Goossens H
J Antimicrob Chemother; 2007 May; 59(5):900-12. PubMed ID: 17369278
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic Susceptibility Testing and Establishment of Tentative Species-Specific Microbiological Cut-off Values for Bifidobacteria Isolated from Chinese Population.
Pei Z; Liu Y; Zhao F; Wang H; Zhao J; Chen W; Lu W
Probiotics Antimicrob Proteins; 2023 Jul; ():. PubMed ID: 37515711
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of Lactobacillus strains isolated from domestic geese.
Dec M; Wernicki A; Puchalski A; Urban-Chmiel R
Br Poult Sci; 2015; 56(4):416-24. PubMed ID: 26105622
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility testing of lactic acid bacteria and bifidobacteria by broth microdilution method and Etest.
Kushiro A; Chervaux C; Cools-Portier S; Perony A; Legrain-Raspaud S; Obis D; Onoue M; van de Moer A
Int J Food Microbiol; 2009 Jun; 132(1):54-8. PubMed ID: 19361877
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of bifidobacteria.
Moubareck C; Gavini F; Vaugien L; Butel MJ; Doucet-Populaire F
J Antimicrob Chemother; 2005 Jan; 55(1):38-44. PubMed ID: 15574479
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products.
D'Aimmo MR; Modesto M; Biavati B
Int J Food Microbiol; 2007 Apr; 115(1):35-42. PubMed ID: 17198739
[TBL] [Abstract][Full Text] [Related]
12. Resistance of Bifidobacteria Toward Antibiotics.
Gueimonde M; Arboleya S
Methods Mol Biol; 2021; 2278():195-208. PubMed ID: 33649958
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility testing of Bifidobacterium thermophilum and Bifidobacterium pseudolongum strains: broth microdilution vs. agar disc diffusion assay.
Domig KJ; Mayrhofer S; Zitz U; Mair C; Petersson A; Amtmann E; Mayer HK; Kneifel W
Int J Food Microbiol; 2007 Nov; 120(1-2):191-5. PubMed ID: 17884216
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of bifidobacteria.
Lim KS; Huh CS; Baek YJ
J Dairy Sci; 1993 Aug; 76(8):2168-74. PubMed ID: 8408866
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
Sader HS; Jones RN; Ballow CH; Biedenbach DJ; Cered RF;
Braz J Infect Dis; 2001 Feb; 5(1):21-31. PubMed ID: 11290311
[TBL] [Abstract][Full Text] [Related]
17. Campylobacter and fluoroquinolones: a bias data set?
Silley P
Environ Microbiol; 2003 Apr; 5(4):219-30. PubMed ID: 12662169
[TBL] [Abstract][Full Text] [Related]
18. Microbiological Cutoff Values: A Critical Issue in Phenotypic Antibiotic Resistance Assessment of Lactobacilli and Bifidobacteria.
Połka J; Morelli L; Patrone V
Microb Drug Resist; 2016 Dec; 22(8):696-699. PubMed ID: 27030947
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of bifidobacteria to lysozyme as a possible selection criterion for probiotic bifidobacterial strains.
Rada V; Splichal I; Rockova S; Grmanova M; Vlkova E
Biotechnol Lett; 2010 Mar; 32(3):451-5. PubMed ID: 19943182
[TBL] [Abstract][Full Text] [Related]
20. Intra- and interlaboratory performances of two commercial antimicrobial susceptibility testing methods for bifidobacteria and nonenterococcal lactic acid bacteria.
Huys G; D'Haene K; Cnockaert M; Tosi L; Danielsen M; Flórez AB; Mättö J; Axelsson L; Korhonen J; Mayrhofer S; Egervärn M; Giacomini M; Vandamme P
Antimicrob Agents Chemother; 2010 Jun; 54(6):2567-74. PubMed ID: 20385863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
